Cholesterol biosynthesis in Zellweger syndrome: Normal activity of mevalonate kinase, mevalonate-5′-pyrophosphate decarboxylase and IPP-isomerase in patients' fibroblasts but deficient mevalonate kinase activity in liver

Journal of Inherited Metabolic Disease

Volumn 19, Issue 2, 1996, Pages 193-196

  Wanders, R J A ^a   Romeijn, G J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLYASE; CHOLESTEROL; IPP ISOMERASE; ISOMERASE; LOW DENSITY LIPOPROTEIN; MEVALONATE 5' PYROPHOSPHATE DECARBOXYLASE; MEVALONIC ACID; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONFERENCE PAPER; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; LIVER; ZELLWEGER SYNDROME;

CARBON-CARBON DOUBLE BOND ISOMERASES; CARBOXY-LYASES; CHOLESTEROL; FIBROBLASTS; HUMANS; ISOMERASES; LIVER; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); ZELLWEGER SYNDROME;

EID: 0029878455     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01799427     Document Type: Article

References (13)

1. Appelkvist E, Reinhart M, Fischer R, Billheimer J, Dallner G (1990) Presence of individual enzymes of cholesterol biosynthesis in rat liver peroxisomes. Arch Biochem Biophys 282: 318-325.
2. Dodt G, Braverman N, Wong C, et al (1995) Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nature Genet 9: 115-125.
3. Hodge VJ, Gould SJ, Subramani S, Moser HW, Krisans SK (1991) Normal cholesterol synthesis in human cells requires functional peroxisomes. Biochem Biophys Res Commun 181: 537-541.
4. Keller G-A, Barton MC, Shapiro PJ, Singer SJ (1986) 3-Hydroxy-3-methylglutarylcoenzyme A reductase is present in peroxisomes in normal rat liver cells. Proc Natl Acad Sci USA 82: 770-774.
5. Krisans SK (1992) The role of peroxisomes in cholesterol metabolism. Am J Respir Cell Mol Biol 7: 358-364.
6. Krisans SK, Ericsson J, Edwards PA, Keller G-A (1994) Famesyldiphosphate synthase is localized in peroxisomes. J Biol Chem 269: 14165-14169.
7. Malle E, Oettl K, Sattler W, Hoefler G, Kostner GM (1995) Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin. Eur J Clin Invest 25: 59-67.
8. Mandel H, Getsis M, Rosenblat M, Berant M, Aviram M (1995) Reduced cellular cholesterol content in peroxisome-deficient fibroblasts is associated with impaired uptake of the patient's LDL and with reduced cholesterol synthesis. J Lipid Res 36: 1385-1391.
9. Mitchell ED, Avigan J (1981) Control of phosphorylation and decarboxylation of mevalonic acid and its metabolites in cultured human fibroblasts and in rat liver in vivo, J Biol Chem 256: 6170-6173.
10. Motley A, Hettema E, Distel B, Tabak H (1994) Differential protein import deficiencies in human peroxisome assembly disorders. J Cell Biol 125: 755-767.
11. Poll-The BT, Saudubray JM, Ogier HAM, et al (1987) Infantile Refsum disease: an inherited peroxisomal disorder: comparison with Zellweger syndrome and neonatal adrenoleukodystrophy. Eur J Pediatr 146: 477-483.
12. Slawecki ML, Dodt G, Moser AB, Moser HW, Gould SJ (1995) Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J Cell Biol, in press.
13. Stamellos KD, Shackelford JE, Tanaka RD, Krisans SK (1992) Mevalonate kinase is localized in peroxisomes. J Biol Chem 267: 5560-5568.